Anadol
Turkey's first commercial car producer
Anadol was Turkey's first domestic mass-production passenger vehicle company. Its first model, Anadol A1 (1966–1975) was the second Turkish car after the ill-fated Devrim sedan of 1961. Anadol cars and pick-ups were manufactured by Otosan Otomobil Sanayii in Istanbul between 1966 and 1991.
The brand's name was derived from the Turkish name of Anatolia (Anadolu) and its logo was the Hittite stag.
Seven Anadol models were produced: A1 (1966–1975), A2 (1970–1981), STC-16 (1973–1975), SV-1600 (1973–1982), Böcek (1975–1977), A8-16 (1981–1984) and Otosan P2 500 pick-up (1971–1991).
Production of the Anadol passenger cars was discontinued in 1986, while the production of the Otosan 500 Pick-Up continued until 1991. At present, Otosan builds Ford Motor Company's passenger cars and commercial vehicles, which are exported to numerous countries in the world, particularly to the European Union member states.
Anadol A1 (1966–1975)
The Anadol A1, code named FW5 by Reliant which developed the prototype upon Anadol's request, went into production on 19 December 1966. The styling of the A1 was by Tom Karen of Ogle Design. In 1967, a New Zealand entrepreneur, Alan Gibbs, announced that he intended to also produce the car in his country as the Anziel Nova.
This brief starts where responsible research should: with the source description of “Anadol” as turkey's first commercial car producer. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the general reference register because the source frames it as turkey's first commercial car producer. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated May 27, 2026. The linked authority identifier is Q1814507. 1 of 1 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1966, 1975, 1961 and 1991.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Anadol”, its source revision and the description used here.
- Expand the search: follow Anadol primary sources, Anadol archive and Anadol research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Anadol”?
- Which institution is responsible for the underlying evidence?
- Which cited source is closest to the event, object or claim?
Search terms from this dossier
This entry incorporates text from “Anadol” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.